This inventor holds 19 USPTO granted patents and 18 published patent applications, plus 3 CIPO patents and 4 EPO patents, primarily in Peptidomimetic Macrocycles. Top assignee: Aileron Therapeutics, Inc.. Active years: 2013-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Somerville, MA (US) (2014 - 2016)
- Wayland, MA (US) (2016 - 2019)
- West Roxbury, MA (US) (2013 - 2021)
Company Filing History:
Years Active: 2013-2021
Areas of Expertise:
Title: **Innovations of Noriyuki Kawahata: Pioneering Peptidomimetic Macrocycles**
Introduction
Noriyuki Kawahata, based in West Roxbury, MA, has made significant contributions to the field of biotechnology with a focus on innovative therapeutic solutions. With an impressive portfolio of 19 patents, he stands as a prominent figure in the development of novel medical treatments.
Latest Patents
Kawahata's latest patents include innovations related to peptidomimetic macrocycles. These patents highlight novel macrocycles and the methods for utilizing them in the treatment of diseases, showcasing the potential for advanced therapeutic applications.
Career Highlights
Currently employed by Aileron Therapeutics, Inc., Kawahata has dedicated his career to exploring the intricate mechanisms of peptide mimetics. His extensive research has positioned him at the forefront of biopharmaceutical advancements, contributing to enhanced treatment options in various medical arenas.
Collaborations
Throughout his career, Kawahata has collaborated with esteemed colleagues such as Huw M Nash and Vincent Guerlavais. These partnerships have fostered an environment of innovation and shared knowledge, leading to impactful developments in therapeutic research.
Conclusion
Noriyuki Kawahata exemplifies the spirit of innovation within the biotechnology sector. With his focus on peptidomimetic macrocycles and collaborative efforts within Aileron Therapeutics, he continues to influence the landscape of medical treatments and inspire future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
